|Bid||87.77 x 900|
|Ask||87.85 x 800|
|Day's Range||87.44 - 88.48|
|52 Week Range||61.05 - 88.48|
|Beta (3Y Monthly)||1.09|
|PE Ratio (TTM)||29.30|
|Forward Dividend & Yield||0.88 (1.01%)|
|1y Target Est||N/A|
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space. However, forex remains a woe.
Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International
Within MedSurg, Boston Scientific (BSX) is on track for the year-end launch of Exalt-D Single-Use Duodenoscope, which is used in ERCP procedures.
Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
With the Beckley Canopy Therapeutics acquisition, Canopy Growth's (CGC) research and development endeavors would be expanding worldwide, thereby making the company a global pioneer in cannabinoid research.
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.